✦ LIBER ✦

244 Prostate Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC): a Phase 1 Trial in Castration-Resistant Metastatic Prostate Cancer (mCRPC)

✍ Scribed by Petrylak, D.; Kantoff, P.; Mega, A.; Stephenson, J.; Vogelzang, N.; Fleming, M.; Blattman, S.; Stambler, N.; D'Ambrosio, P.; Israel, R.J.

Book ID: 123579992
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 59 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(12)72042-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

870 A phase 2 trial of prostate specific

870 A phase 2 trial of prostate specific membrane antigen antibody drug conjugate (PSMA ADC) in taxane-treated metastatic castration-resistant prostate cancer (MCRPC)

✍ Petrylak, D.; Smith, D.C.; Appleman, L.J.; Fleming, M.; Hussain, A.; Dreicer, R. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 201 KB

MP70-20 A PHASE 2 TRIAL OF PROSTATE SPEC

MP70-20 A PHASE 2 TRIAL OF PROSTATE SPECIFIC MEMBRANE ANTIGEN ANTIBODY DRUG CONJUGATE (PSMA ADC) IN TAXANE-TREATED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)

✍ Petrylak, Daniel; Smith, David C.; Appleman, Leonard J.; Fleming, Mark; Hussain, 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 311 KB

Ipilimumab and a poxviral vaccine target

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

✍ Ravi A Madan; Mahsa Mohebtash; Philip M Arlen; Matteo Vergati; Myrna Rauckhorst; 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 138 KB

PHASE 2a TRIAL OF 177LUTETIUM RADIOLABEL

PHASE 2a TRIAL OF 177LUTETIUM RADIOLABELED ANTI- PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) MONOCLONAL ANTIBODY J591 (177Lu-J591) IN PATIENTS (PTS) WITH METASTATIC ANDROGEN-INDEPENDENT PROSTATE CANCER (AIPC)

✍ Bander, Neil H; Nanus, David M; Tagawa, Scott; Vallabhajosula, Shankar; Goldsmit 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 125 KB

Phase I rapid dose-escalation study of A

Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial

✍ Emmanuel S. Antonarakis; Michael A. Carducci; Mario A. Eisenberger; Samuel R. De 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 316 KB